Geriatric brain tumor management part II: Glioblastoma multiforme

Area of Science:

• Geriatric Medicine
• Neuro-oncology
• Clinical Neurology

Background:

• The elderly population is rapidly growing, necessitating specialized care for age-related health conditions.
• Frailty is a key concept in geriatric medicine, correlating with adverse outcomes and survival.
• Intracranial neoplasms present unique challenges in geriatric patients, requiring tailored management strategies.

Purpose of the Study:

• To review the specific management of Glioblastoma-Multiforme (GBM) in elderly patients.
• To highlight the challenges and controversies surrounding GBM treatment in the geriatric population.
• To emphasize the importance of a comprehensive geriatric assessment in guiding treatment decisions.

Main Methods:

• Review of current literature on GBM management in the elderly.
• Analysis of age as a prognostic factor and risk factor for GBM.
• Discussion of treatment efficacy and toxicity concerns in older adults.

Main Results:

• Glioblastoma-Multiforme (GBM) is the most common primary brain tumor in adults, with cases in the elderly expected to double.
• Elderly GBM patients often experience a more aggressive disease course with poorer outcomes and treatment resistance.
• Optimal management strategies for elderly GBM patients remain controversial due to concerns about treatment effectiveness and toxicity.

Conclusions:

• Treatment decisions for elderly GBM patients require careful consideration of individual health status and potential treatment risks.
• Comprehensive geriatric assessment is essential for optimizing care and decision-making in older adults with GBM.
• Further research is needed to establish evidence-based guidelines for GBM management in the geriatric population.